Pliant Therapeutics
PLRX
Pliant Therapeutics (PLRX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Canaccord Genuity | Maintained | Hold | $3.00 from $4.00 | Mar 13, 2026 |
| Piper Sandler | Maintained | Overweight | $3.00 from $4.00 | Mar 12, 2026 |
| RBC Capital | Maintained | Sector Perform | $2.00 from $3.00 | Nov 7, 2025 |
| JP Morgan | Downgraded | Neutral → Underweight | — | Oct 10, 2025 |
| Piper Sandler | Maintained | Overweight | $4.00 from $17.00 | Aug 8, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | — | Mar 18, 2025 |
| Needham | Downgraded | Buy → Hold | $10.00 | Mar 4, 2025 |
| Wells Fargo | Maintained | Equal-Weight | $3.00 from $4.00 | Mar 4, 2025 |
| RBC Capital | Maintained | Sector Perform | $3.00 from $4.00 | Mar 4, 2025 |
| Cantor Fitzgerald | Maintained | Neutral | — | Mar 4, 2025 |
| Citigroup | Maintained | Neutral | $1.50 from $4.00 | Mar 4, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | — | Mar 4, 2025 |
| Needham | Maintained | Buy | $10.00 | Feb 14, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | — | Feb 14, 2025 |
| HC Wainwright & Co. | Downgraded | Buy → Neutral | — | Feb 10, 2025 |
| Needham | Maintained | Buy | $10.00 from $38.00 | Feb 10, 2025 |
| Citigroup | Downgraded | Buy → Neutral | $4.00 from $44.00 | Feb 10, 2025 |
| Wells Fargo | Downgraded | Overweight → Equal-Weight | $4.00 from $41.00 | Feb 10, 2025 |
| Canaccord Genuity | Downgraded | Buy → Hold | $4.00 | Feb 10, 2025 |
| RBC Capital | Downgraded | Outperform → Sector Perform | $4.00 from $45.00 | Feb 10, 2025 |
Frequently asked questions
What is the latest analyst rating on PLRX?
On Mar 13, 2026, Canaccord Genuity maintained Pliant Therapeutics at Hold with a price target of $3.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.